株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

非侵襲的出生前検査 (NIPT) の世界市場の予測 〜2021年:機器 (超音波・NGS・PCR・マイクロアレイ)・消耗品・手法・用途・エンドユーザー別

Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 485003
出版日 ページ情報 英文 152 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
非侵襲的出生前検査 (NIPT) の世界市場の予測 〜2021年:機器 (超音波・NGS・PCR・マイクロアレイ)・消耗品・手法・用途・エンドユーザー別 Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
出版日: 2017年03月31日 ページ情報: 英文 152 Pages
概要

世界の非侵襲的出生前検査 (NIPT) の市場は予測期間中16.4%のCAGR (年間複合成長率) で推移し、2016年の13億5000万米ドルから、2021年には28億8000万米ドルの規模に成長すると予測されています。非侵襲的技法の人気の拡大、NIPTの償還に対する焦点の拡大、先進的NIPT製品の市場投入、母体年齢の上昇などの要因が同市場の成長を推進しています。

当レポートでは、世界の非侵襲的出生前検査 (NIPT) の市場を調査し、市場および検査の定義と概要、市場成長への各種影響因子および市場機会の分析、製品区分・手法・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 消耗品市場の実績・予測:タイプ別
  • 検査機器市場の実績・予測:タイプ別
  • 市場分析:地域・手法別
  • 用途別市場の予測
  • 市場の実績・予測:エンドユーザ別
  • 市場の実績・予測:地域別

第5章 市場概要

  • イントロダクション
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 市場分析:製品別

  • イントロダクション
  • 消耗品
    • アッセイキット・試薬
    • ディスポーザブル品
  • 機器
    • 超音波デバイス
    • 次世代シーケンシングシステム
    • ポリメラーゼ連鎖反応関連機器
    • マイクロアレイ
    • その他

第7章 市場分析:手法別

  • イントロダクション
  • 超音波検出
  • 生化学的スクリーニング検査
  • 母体血漿中のセルフリーDNAの検査
  • 母体血液中の胎児細胞の検査

第8章 市場分析:用途

  • イントロダクション
  • トリソミー
  • 微小欠失症候群
  • その他

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 診断ラボ
  • 病院

第10章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア
  • その他

第11章 競合環境

  • 概要
  • 市場分析
  • 競合状況・動向
    • 提携・協力・合意
    • 製品投入
    • 買収
    • 拡張
    • その他の戦略

第12章 企業プロファイル

  • イントロダクション
  • GE HEALTHCARE
  • KONINKLIJKE PHILIPS N.V.
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • F. HOFFMAN-LA ROCHE LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • PERKINELMER, INC.
  • QIAGEN N.V.
  • AGILENT TECHNOLOGIES, INC.
  • BEIJING GENOMICS INSTITUTE

第13章 付録

目次
Product Code: BT 5140

The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

By product, the non-invasive prenatal testing market is segmented into consumables and instruments. In 2016, the consumables segment accounted for the largest share of the market. The high demand due to the recurring requirement of consumables as compared to instruments is a key driver for the growth of this product segment.

On the basis of method, the market is segmented into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. The ultrasound detection segment dominated the market in 2016. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR. This is mainly attributed to the increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services.

On the basis of application, the market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy commands the largest and fastest-growing application segment of the global market in 2016. This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities.

On the basis of end user, the market is classified into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and increasing initiatives by companies to provide advanced equipment to diagnostic laboratories.

North America commanded the largest share of the global market in 2016. Asia is expected to grow at the highest CAGR during the forecast period. The high growth in the Asian market is attributed to increasing disposable income, rising healthcare infrastructure, rising awareness programs and conferences, and increasing focus of market players in this region. Some prominent markets in Asia include China, India, and Japan.

Research Coverage:

This market is categorized on the basis of product, method, application, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the NIPT market. The report analyzes the non-invasive prenatal testing market by product, method, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the NIPT market.
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the NIPT market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for NIPT across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the NIPT market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NON-INVASIVE PRENATAL TESTING: MARKET OVERVIEW
  • 4.2. NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2016 VS. 2021(USD MILLION)
  • 4.3. NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2016 VS. 2021(USD MILLION)
  • 4.4. GEOGRAPHIC ANALYSIS: NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD (2016)
  • 4.5. NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (2016-2021)
  • 4.6. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2016 VS. 2021(USD MILLION)
  • 4.7. GEOGRAPHIC SNAPSHOT: NON-INVASIVE PRENATAL TESTING MARKET (2016-2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DRIVERS
      • 5.1.1.1. High risk of chromosomal abnormalities with increasing maternal age
      • 5.1.1.2. Growing preference for non-invasive techniques over invasive methods
      • 5.1.1.3. Launch of new and advanced products
      • 5.1.1.4. Improving reimbursement scenario for NIPT
      • 5.1.1.5. Programs focusing on increasing the awareness of NIPT
    • 5.1.2. RESTRAINT
      • 5.1.2.1. Lack of skilled professionals
    • 5.1.3. OPPORTUNITY
      • 5.1.3.1. Untapped emerging markets
    • 5.1.4. CHALLENGE
      • 5.1.4.1. Reliability of test results especially in obese women

6. NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. ASSAY KITS & REAGENTS
    • 6.2.2. DISPOSABLES
  • 6.3. INSTRUMENTS
    • 6.3.1. ULTRASOUND DEVICES
    • 6.3.2. NEXT-GENERATION SEQUENCING SYSTEMS
    • 6.3.3. POLYMERASE CHAIN REACTION INSTRUMENTS
    • 6.3.4. MICROARRAYS
    • 6.3.5. OTHER INSTRUMENTS

7. NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD

  • 7.1. INTRODUCTION
  • 7.2. ULTRASOUND DETECTION
  • 7.3. BIOCHEMICAL SCREENING TESTS
  • 7.4. CELL-FREE DNA IN MATERNAL PLASMA TESTS
  • 7.5. FETAL CELLS IN MATERNAL BLOOD TESTS

8. NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. TRISOMY
  • 8.3. MICRODELETION SYNDROME
  • 8.4. OTHER APPLICATIONS

9. NON-INVASIVE PRENATAL TESTING MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTIC LABORATORIES
  • 9.3. HOSPITALS

10. NON-INVASIVE PRENATAL TESTING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. REST OF EUROPE (ROE)
  • 10.4. ASIA
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PARTNERSHIPS, COLLABORATIONS, & AGREEMENTS
    • 11.3.2. PRODUCT LAUNCHES
    • 11.3.3. ACQUISITIONS
    • 11.3.4. EXPANSIONS
    • 11.3.5. OTHER STRATEGIES

12. COMPANY PROFILE (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 12.3. KONINKLIJKE PHILIPS N.V.
  • 12.4. ILLUMINA, INC.
  • 12.5. THERMO FISHER SCIENTIFIC, INC.
  • 12.6. F. HOFFMAN-LA ROCHE LTD.
  • 12.7. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • 12.8. PERKINELMER, INC.
  • 12.9. QIAGEN N.V.
  • 12.10. AGILENT TECHNOLOGIES, INC.
  • 12.11. BEIJING GENOMICS INSTITUTE

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INCIDENCE RATE OF TRISOMIES
  • TABLE 2: RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE
  • TABLE 3: COMPARISON OF NON-INVASIVE AND INVASIVE PRENATAL TESTING
  • TABLE 4: NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
  • TABLE 5: PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
  • TABLE 6: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL NIPT CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL NIPT CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: NORTH AMERICA: NIPT CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: EUROPE: NIPT CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL NIPT ASSAY KITS AND REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL NIPT DISPOSABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL NIPT INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL NIPT INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NORTH AMERICA: NIPT INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: EUROPE: NIPT INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL NIPT ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL NIPT NEXT-GENERATION SEQUENCING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL NIPT PCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL NIPT MICROARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHER NIPT INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR ULTRASOUND DETECTION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR ULTRASOUND DETECTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR ULTRASOUND DETECTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR BIOCHEMICAL SCREENING TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR CFDNA IN MATERNAL PLASMA TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR FCMB TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR FCMB TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR FCMB TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 36: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR TRISOMY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR TRISOMY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR TRISOMY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR MICRODELETION SYNDROME, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR MICRODELETION SYNDROME, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE MICRODELETION SYNDROME, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 46: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 58: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: U.S.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: U.S.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 62: U.S.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 63: U.S.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: CANADA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: CANADA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 66: CANADA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 67: CANADA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 70: EUROPE: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 74: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: GERMANY: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: GERMANY: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 77: GERMANY: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 78: GERMANY: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 90  
  • TABLE 79: FRANCE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 80: FRANCE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 81: FRANCE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: FRANCE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: U.K.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021(USD MILLION)
  • TABLE 84: U.K.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021(USD MILLION)
  • TABLE 85: U.K.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: U.K.: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: ROE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 88: ROE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 89: ROE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 90: ROE: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 91: ASIA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 92: ASIA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: ASIA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ASIA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 95: ASIA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 96: ASIA: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 97: ROW: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 98: ROW: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: ROW: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: ROW: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 101: ROW: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 102: ROW: NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 103: NON-INVASIVE PRENATAL TESTING MARKET RANKING, BY KEY PLAYER, 2015
  • TABLE 104: PARTNERSHIPS, COLLABORATIONS, & AGREEMENTS (2014-2017) 107  
  • TABLE 105: PRODUCT LAUNCHES (2014-2017)
  • TABLE 106: ACQUISITIONS (2014-2017)
  • TABLE 107: EXPANSIONS (2014-2017)
  • TABLE 108: OTHER STRATEGIES (2014-2017)
  • TABLE 109: EXCHANGE RATE (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 110: EXCHANGE RATE (USED FOR THE CONVERSION OF CHF TO USD)

LIST OF FIGURES

  • FIGURE 1: NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 8: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 9: NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: NON-INVASIVE PRENATAL TESTING MARKET, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: NORTH AMERICA DOMINATED THE GLOBAL NON-INVASIVE PRENATAL TESTING MARKET IN 2016
  • FIGURE 14: HIGH RISK OF CHROMOSOMAL ABNORMALITY ASSOCIATED WITH INCREASING MATERNAL AGE IS DRIVING THE MARKET GROWTH FOR NON-INVASIVE PRENATAL TESTING
  • FIGURE 15: ASSAY KITS & REAGENTS DOMINATED THE NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET IN 2016
  • FIGURE 16: NGS SYSTEMS TO REGISTER THE HIGHEST CAGR IN THE NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET FROM 2016 TO 2021
  • FIGURE 17: ULTRASOUND DETECTION COMMANDED THE LARGEST SHARE OF THE NON-INVASIVE PRENATAL TESTING MARKET IN 2016
  • FIGURE 18: TRISOMY WAS THE LARGEST APPLICATION SEGMENT IN THE NON-INVASIVE PRENATAL TESTING MARKET IN 2016
  • FIGURE 19: DIAGNOSTIC LABORATORIES DOMINATED THE NON-INVASIVE PRENATAL TESTING MARKET IN 2016
  • FIGURE 20: ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: NIPT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 23: CONSUMABLES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: CFDNA IN MATERNAL PLASMA TESTS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO DOMINATE THE MARKET DURING FORECAST PERIOD
  • FIGURE 26: ASIA TO WITNESS HIGHEST GROWTH IN THE BIOCHEMICAL SCREENING TESTS MARKET DURING 2016-2021
  • FIGURE 27: ASIA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 28: NORTH AMERICA TO DOMINATE THE FCMB TESTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: TRISOMY TO DOMINATE THE NIPT MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
  • FIGURE 30: DIAGNOSTIC LABORATORIES DOMINATED THE NON-INVASIVE PRENATAL TESTING END-USER MARKET IN 2016
  • FIGURE 31: NORTH AMERICA TO DOMINATE THE NON-INVASIVE PRENATAL TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 33: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 34: ASIA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 35: ROW: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 36: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2016
  • FIGURE 37: MARKET EVOLUTION FRAMEWORK
  • FIGURE 38: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 39: PRODUCT MIX OF THE TOP PLAYERS IN THE NIPT MARKET
  • FIGURE 40: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 41: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 42: ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 43: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 44: F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2016)
  • FIGURE 45: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 46: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 47: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 48: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2016)
Back to Top